MDE Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$1.65M Hold
16,802
0.42% 11
2014
Q4
$1.58M Hold
16,802
0.39% 11
2014
Q3
$1.79M Sell
16,802
-471
-3% -$46.1K 0.44% 11
2014
Q2
$1.43M Sell
17,273
-256
-1% -$19.9K 0.33% 13
2014
Q1
$1.24M Buy
17,529
+22
+0.1% +$1.73K 0.25% 15
2013
Q4
$1.31M Hold
17,507
0.22% 14
2013
Q3
$1.1M Sell
17,507
-26
-0.1% -$1.55K 0.18% 15
2013
Q2
$899K Buy
+17,533
New +$914K 0.14% 15

Other funds holding GILD

MDE Group's GILD Position: Q1 2015 in Review

MDE Group held its Gilead Sciences (GILD) position steady in Q1 2015 at 16,802 shares worth $1.65M. The position accounts for 0.42% of the portfolio, ranked #11.

MDE Group first reported a position in GILD in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.79M in Q3 2014. 1,493 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • MDE Group held 16,802 shares of Gilead Sciences worth $1.65M as of Q1 2015.
  • MDE Group left its Gilead Sciences share count unchanged in Q1 2015.
  • Gilead Sciences made up 0.42% of MDE Group's portfolio in Q1 2015, its #11 holding.
  • MDE Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 8 quarters since.
  • MDE Group's Gilead Sciences position peaked at $1.79M in Q3 2014.
  • 1,493 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on MDE Group's 13F filing for Q1 2015, filed 22 Apr 2015.